Catalyst Wire Dossier Catalyst Wire Dossier

ibrexafungin

ibrexafungep · Scynexis, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ibrexafungin, covering 2021-08-12 to 2021-08-12. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis [Phase 2]

See pricing